A Robust Automated Measure of Average Antibody Staining in Immunohistochemistry Images
暂无分享,去创建一个
Kingshuk Roy Choudhury | Kenneth A. Krohn | Paul E. Swanson | K. Krohn | K. Choudhury | P. Swanson | J. Rajendran | Kevin J. Yagle | Joseph G. Rajendran | K. Yagle
[1] J. Grandis. Prognostic Biomarkers in Head and Neck Cancer , 2006, Clinical Cancer Research.
[2] T. J. Breen,et al. Biostatistical Analysis (2nd ed.). , 1986 .
[3] W. Sauerbrei,et al. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. , 1994, Journal of the National Cancer Institute.
[4] R. Bast,et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] E. Schiffer. Biomarkers for prostate cancer , 2007, World Journal of Urology.
[6] C K Osborne,et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Sm Hus. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures , 1981 .
[8] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[9] L. Shepp,et al. Maximum Likelihood Reconstruction for Emission Tomography , 1983, IEEE Transactions on Medical Imaging.
[10] R. Osamura,et al. Utility of immunohistochemistry in breast cancer practice , 2004, Breast cancer.
[11] W. Hanna. Testing for HER2 Status , 2001, Oncology.
[12] G. Mccluggage,et al. Immunohistochemistry as a diagnostic aid in cervical pathology , 2007, Pathology.
[13] I. Lossos,et al. Prognostic biomarkers in diffuse large B-cell lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Thomas J. Smith,et al. 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] D. Allred,et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[16] Tomoyuki Kato,et al. Cytometrical image analysis for immunohistochemical hormone receptor status in breast carcinomas , 2003, Pathology international.